• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者的钙敏性血管炎:一项患病率研究。

Calciphylaxis in patients on hemodialysis: a prevalence study.

作者信息

Angelis M, Wong L L, Myers S A, Wong L M

机构信息

Department of Surgery, John A Burns School of Medicine, University of Hawaii, Honolulu, USA.

出版信息

Surgery. 1997 Dec;122(6):1083-9; discussion 1089-90. doi: 10.1016/s0039-6060(97)90212-9.

DOI:10.1016/s0039-6060(97)90212-9
PMID:9426423
Abstract

BACKGROUND

Calciphylaxis is characterized by painful, violaceous, mottled skin lesions (livedo reticularis) that may progress to tissue necrosis, nonhealing ulcers, gangrene, and potentially amputation, sepsis, or death. The prevalence and characteristics of patients who have calciphylaxis need further identification to predict which patients on dialysis may benefit from close monitoring or early surgical intervention.

METHODS

All 242 patients undergoing hemodialysis in an outpatient unit were reviewed retrospectively during a 15-month cross-sectional study of the prevalence and characteristics of calciphylaxis.

RESULTS

Ten patients (prevalence, 4.1%) had calciphylaxis. Patients with calciphylaxis were significantly younger (49 versus 60 years; p = 0.01), had undergone hemodialysis longer (80 versus 20 months; p < 0.0001), and had higher median serum calcium (9.7 versus 9.2 mg/dl; p = 0.03), phosphate (8.2 versus 5.7 mg/dl; p = 0.001), calcium phosphate product (81.5 versus 52.9; p = 0.0004), parathyroid hormone (1496 versus 138 pg/ml; p < 0.0001), and alkaline phosphatase levels (188 versus 89 IU/L; p = 0.0001). Bone surveys were positive in all 10 patients with calciphylaxis compared with 49 (21%) of the 232 patients without calciphylaxis (p < 0.0001). All patients who underwent parathyroidectomy for calciphylaxis had dramatic healing of the ulcers.

CONCLUSIONS

The presence of calciphylaxis is higher among younger patients who had undergone longer periods of hemodialysis. Therefore this group of patients should be monitored aggressively and treated expeditiously for complications of secondary hyperparathyroidism.

摘要

背景

钙过敏症的特征为疼痛性、紫红色、斑驳状皮肤损害(网状青斑),可进展为组织坏死、不愈合溃疡、坏疽,并可能导致截肢、败血症或死亡。需要进一步明确钙过敏症患者的患病率和特征,以预测哪些透析患者可能从密切监测或早期手术干预中获益。

方法

在一项为期15个月的关于钙过敏症患病率和特征的横断面研究中,对门诊接受血液透析的所有242例患者进行了回顾性分析。

结果

10例患者(患病率为4.1%)患有钙过敏症。患有钙过敏症的患者明显更年轻(49岁对60岁;p = 0.01),血液透析时间更长(80个月对20个月;p < 0.0001),血清钙中位数更高(9.7mg/dl对9.2mg/dl;p = 0.03),磷酸盐(8.2mg/dl对5.7mg/dl;p = 0.001),钙磷乘积(81.5对52.9;p = 0.0004),甲状旁腺激素(1496pg/ml对138pg/ml;p < 0.0001),以及碱性磷酸酶水平(188IU/L对89IU/L;p = 0.0001)。与232例无钙过敏症患者中的49例(21%)相比,所有10例钙过敏症患者的骨扫描均呈阳性(p < 0.0001)。所有因钙过敏症接受甲状旁腺切除术的患者溃疡均显著愈合。

结论

在接受血液透析时间较长的年轻患者中,钙过敏症的发生率较高。因此,应对这组患者进行积极监测,并对继发性甲状旁腺功能亢进的并发症进行及时治疗。

相似文献

1
Calciphylaxis in patients on hemodialysis: a prevalence study.血液透析患者的钙敏性血管炎:一项患病率研究。
Surgery. 1997 Dec;122(6):1083-9; discussion 1089-90. doi: 10.1016/s0039-6060(97)90212-9.
2
Calciphylaxis in secondary hyperparathyroidism. Diagnosis and parathyroidectomy.继发性甲状旁腺功能亢进中的钙质沉着症。诊断与甲状旁腺切除术。
Arch Surg. 1991 Oct;126(10):1213-8; discussion 1218-9. doi: 10.1001/archsurg.1991.01410340055008.
3
Calciphylaxis and nonhealing wounds: the role of the vascular surgeon in a multidisciplinary treatment.钙过敏症与难愈合伤口:血管外科医生在多学科治疗中的作用
J Vasc Surg. 2003 Mar;37(3):501-7. doi: 10.1067/mva.2003.70.
4
Is calciphylaxis best treated surgically or medically?钙过敏症的最佳治疗方法是手术治疗还是药物治疗?
Surgery. 2000 Dec;128(6):967-71;discussion 971-2. doi: 10.1067/msy.2000.110429.
5
Therapy for calciphylaxis: an outcome analysis.钙过敏症的治疗:一项结果分析。
Surgery. 2003 Dec;134(6):941-4; discussion 944-5. doi: 10.1016/j.surg.2003.07.001.
6
Calciphylaxis after parathyroidectomy.甲状旁腺切除术后的钙化防御。
Hemodial Int. 2017 Oct;21 Suppl 2:S62-S66. doi: 10.1111/hdi.12599.
7
Long-term outcomes in patients with calciphylaxis from hyperparathyroidism.甲状旁腺功能亢进所致钙过敏患者的长期预后
Ann Surg Oncol. 2006 Jan;13(1):96-102. doi: 10.1245/ASO.2006.03.042. Epub 2006 Jan 1.
8
Painful skin ulcers in a hemodialysis patient.一名血液透析患者出现疼痛性皮肤溃疡。
Clin J Am Soc Nephrol. 2014 Jan;9(1):166-73. doi: 10.2215/CJN.00320113. Epub 2013 Nov 7.
9
Multidisciplinary management of calciphylaxis: a series of 5 patients at a single facility.钙过敏的多学科管理:单机构的5例患者系列研究
CEN Case Rep. 2020 May;9(2):122-128. doi: 10.1007/s13730-019-00439-8. Epub 2019 Dec 17.
10
Calciphylaxis: early recognition and management.钙过敏症:早期识别与处理
Am Surg. 1994 Feb;60(2):81-6.

引用本文的文献

1
A Case Report of Calciphylaxis.钙化防御病例报告
J Educ Teach Emerg Med. 2025 Jul 31;10(3):V27-V30. doi: 10.21980/J8KW8V. eCollection 2025 Jul.
2
Ten tips on how to deal with calciphylaxis patients.关于如何应对钙过敏症患者的十条建议。
Clin Kidney J. 2025 Apr 9;18(4):sfaf098. doi: 10.1093/ckj/sfaf098. eCollection 2025 Apr.
3
Successful Management of Calciphylaxis with Sodium Thiosulfate in End-Stage Renal Disease: A Case Report.硫代硫酸钠成功治疗终末期肾病患者的钙化防御:一例报告
Healthcare (Basel). 2025 Jan 31;13(3):282. doi: 10.3390/healthcare13030282.
4
Clinical characteristics and prognosis of dialysis patients with metastatic calcification diagnosed by 99mTc-MDP bone scintigraphy.经99mTc-MDP骨显像诊断的透析患者转移性钙化的临床特征及预后
Sci Rep. 2025 Jan 2;15(1):472. doi: 10.1038/s41598-024-84633-4.
5
Calcific Uremic Arteriolopathy (CUA) Among Malaysian Dialysis Patients: Clinical Characteristics, Treatment, and Outcomes.马来西亚透析患者中的钙化性尿毒症小动脉病(CUA):临床特征、治疗及结局
Cureus. 2024 Nov 14;16(11):e73711. doi: 10.7759/cureus.73711. eCollection 2024 Nov.
6
Clinical characteristics and treatment modalities in uremic and non uremic calciphylaxis - a dermatological single-center experience.尿毒症性和非尿毒症性钙化防御的临床特征和治疗方式:一项皮肤科单中心经验。
Ren Fail. 2024 Dec;46(1):2297566. doi: 10.1080/0886022X.2023.2297566. Epub 2024 Jan 4.
7
Early diagnosis strategy of calciphylaxis in dialysis patients.透析患者钙化防御的早期诊断策略。
Ren Fail. 2023;45(2):2264407. doi: 10.1080/0886022X.2023.2264407. Epub 2023 Oct 5.
8
Sodium Thiosulfate for Calciphylaxis Treatment in Patients on Peritoneal Dialysis: A Systematic Review.硫代硫酸钠治疗腹膜透析患者钙化防御:系统评价。
Medicina (Kaunas). 2023 Jul 14;59(7):1306. doi: 10.3390/medicina59071306.
9
Calciphylaxis of the penis and distal digits: a case report.阴茎和远端指(趾)calciphylaxis:病例报告。
J Med Case Rep. 2022 Jan 18;16(1):18. doi: 10.1186/s13256-021-03231-4.
10
Successful Treatment of Calciphylaxis in a Young Female With End-Stage Renal Disease on Peritoneal Dialysis With Parathyroidectomy, Intensification of Dialysis, and Sodium Thiosulphate-A Case Report and Literature Review.甲状旁腺癌相关钙化防御的治疗:甲状旁腺切除术、强化透析和硫代硫酸钠治疗腹膜透析终末期肾病年轻女性 1 例报告及文献复习
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211060580. doi: 10.1177/23247096211060580.